Purpose
Doctors and advanced practice nurses may not be familiar with the risk factors, clinical presentation and methods for identifying hantavirus disease, as well as parameters for clinical management. As cases of hantavirus persist in the U.S., including the Four Corners region, it is important for medical staff to recognize hantavirus cases in their communities, provide critical care, and report cases appropriately. This page contains information for two trainings on hantavirus disease: Hantavirus disease in the U.S. and Hantavirus disease in the Fourth Corners region.
What you will learn: Hantavirus disease in the U.S.
Hantavirus disease is an uncommon illness in humans; however, cases have occurred in the majority of states across the country. In the U.S., Hantavirus Pulmonary Syndrome, a respiratory disease caused by infection with hantaviruses, is a Nationally Notifiable Disease.
This video provides an overview of hantavirus disease for clinicians. Through this video, clinicians and health care providers will understand the clinical presentation and epidemiology of hantavirus in the U.S. They will also learn methods for diagnostic testing of hantavirus and treatment options.
By the end of this training, you will be able to:
- Describe the epidemiology of hantavirus disease in the U.S
- Describe the clinical presentation of hantavirus disease in the U.S.
- Describe considerations for diagnosing a patient with hantavirus disease.
- Identify the parameters of clinical management for hantavirus disease in the U.S.
- Describe my scope of practice as a team member when diagnosing or treating patients with Hantavirus disease.
Training information: Hantavirus disease in the U.S.
CE origination date: June 3, 2024
CE expiration date: June 3, 2026
Perquisites: General knowledge of infectious diseases.
Format: This activity is web-on-demand.
Instructions for obtaining Continuing Education (CE): Hantavirus disease in the U.S.
To receive continuing education (CE) for WD4849- Hantavirus Disease: What healthcare professionals need to know to recognize, diagnose, and treat hantavirus in the United States, please visit CDC TRAIN and search for the course in the Course Catalog using WD4849. Follow the steps below by June 3, 2028.
- Register for and complete the course.
- Pass the post-assessment with at least 75%.
- Complete the evaluation.
- Visit Your Learning to access your certificates and transcript.
No fees are charged for CDC's CE activities.
What you will learn: Hantavirus disease in the Fourth Corners
Hantavirus disease is an uncommon illness in humans; however, cases have occurred in the majority of states across the country. The Four Corners region in the western part of the U.S., the area where Colorado, Utah, Arizona, and New Mexico meet, has a higher incidence of hantavirus cases as compared to other regions in the country. The majority of the Four Corners region belongs to several Native American nations, including Navajo, Hopi, Ute, and Zuni tribal reserves and nations. Hantavirus Pulmonary Syndrome, a respiratory disease caused by infection with hantaviruses, is a Nationally Notifiable Disease in the U.S.
This video provides an overview of hantavirus disease for clinicians in the Four Corners region of the U.S. Through this video, clinicians and healthcare providers located in the Four Corners region will understand the clinical presentation and epidemiology of hantavirus in the U.S., with a particular focus on the Four Corners region. They will also learn methods for diagnostic testing of hantavirus, options for treatment, and the process for reporting a case of hantavirus disease.
By the end of this training, you will be able to:
- Describe the epidemiology of hantavirus disease in the Four Corners region.
- Describe the clinical presentation of hantavirus disease in the Four Corners region.
- Describe the considerations for clinical management of hantavirus disease in the Four Corners region.
- Describe the patient information required for reporting Hantavirus disease to public health authorities in the Four Corners region.
- Describe my scope of practice as a team member when diagnosing or treating patients with Hantavirus disease.
Training information: Hantavirus disease in the Four Corners
CE origination date: June 3, 2024
CE expiration date: June 3, 2026
Prerequisites: General knowledge of infectious diseases.
Format: This activity is web-on-demand.
Instructions for obtaining Continuing Education (CE): Hantavirus disease in the Four Corners
To receive continuing education (CE) for WD4850- Hantavirus Disease in the Four Corners: What healthcare professionals need to know to recognize, diagnose, and treat hantavirus in the Four Corners Region, please visit CDC TRAIN and search for the course in the Course Catalog using WD4850. Follow the steps below by June 3, 2026.
- Register for and complete the course.
- Pass the post-assessment with at least 75%.
- Complete the evaluation.
- Visit Your Learning to access your certificates and transcript.
No fees are charged for CDC's CE activities.
After registering for the course
Accreditation statement for both trainings
In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 0.5 nursing contact hours.
After credit is claimed, an unofficial statement of credit is immediately available on CDC TRAIN. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
Disclosure: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies during the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.